Agilent Technologiesthe world leader in electronic instrumentation and life sciences (with sales of $6.6 billion in 2011), has strengthened its two core businesses in quick succession, with the acquisition of the data transmission test business of US company Centellax and in the field of diagnostic tools for cancer, the Danish company Dako. Agilent Technologies has invested $2.2 billion to take control of Dakowith sales of 340 M$ and around 1,000 employees, most of whom are based in Denmark.
The buyback of Dako further reinforces its pre-eminence within theAgilent from the life sciences sector to that of electronic instrumentation...
Learn more: www.home.agilent.com/agilent/home.jspx?cc=FR&lc=fre